Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2023-A00189-36 | Other Identifier | ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Hypertension is the most frequent chronic pathology in France and in the world. It is one of the main modifiable cardiovascular risk factors. In France, 50% of treated hypertensives are uncontrolled and only 30% of treated patients are fully adherent to their antihypertensive treatment. Poor adherence to drug treatments is considered as one of the main causes of non-control of hypertension.
Since 2018, a new profession has entered the French healthcare system: Advanced Practice Nurses (APN). They have many broad skills, at the interface of nursing and medical exercises.
The purpose of this interventional study is to assess the impact of APN on blood pressure (BP) control in the context of usual care of hypertension thanks to a better adhesion of patients and a better therapeutic alliance.
The hypothesis formulated is that an individual APN intervention, included in a usual hypertension management, improves BP control.
This study will be a prospective, open-label, randomized 1-to-1 and monocentric trial, conducted at the Diagnosis and Therapeutic Center of the Hôtel-Dieu University Hospital, Assistance Publique - Hôpitaux de Paris, France.
Recruitment will be conducted during the ambulatory hospitalization. After the signature of the consent form, the randomization will be conducted during the ambulatory hospitalization. All recruited patients will be randomized.
According to the randomization, the odd-numbered participants will constitute the "usual care" group, and the even-numbered patients will constitute the "intervention" group.
The "usual care" group will keep a traditional follow-up: ambulatory hospitalization then consultation with a MD within approximately 2 to 12 months.
The "intervention" group will meet the APN between the ambulatory hospitalization and the MD consultation, within 1 to 6 months.
The participants will get their study appointment(s) (MD consultation +/- APN intervention) at the end of the ambulatory hospitalization according to their allocation.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Interventional group | Experimental | The interventional group meets an Advanced Practice Nurses (APN) between the ambulatory hospitalization (AH) and the MD consultation |
|
| Control group | No Intervention | The control group of patients keeps a traditional follow-up (ambulatory hospitalization (AH) then consultation with a MD) |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| APN intervention | Other | Advanced Practice Nurses (APN) intervention between the ambulatory hospitalization (AH) and the MD consultation APN intervention is divided into five main steps:
|
| Measure | Description | Time Frame |
|---|---|---|
| Blood pressure control | Blood pressure < 140/90 mmHg | Medical consultation, from 2 months to 12 months after inclusion |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of patients who brought HBPM to consultation | Ability to realize a home blood pressure measurement Blood pressure control in home blood pressure measurement (HBPM) | Medical consultation, from 2 months to 12 months after inclusion |
| Number of measurements |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Juliette VAY-DEMOUY, MSc, PhD student | Contact | 0033142348551 | juliette.vaydemouy@aphp.fr | |
| Marie BENHAMMANI-GODARD | Contact | 0033158411190 | marie.godard@aphp.fr |
| Name | Affiliation | Role |
|---|---|---|
| Jacques BLACHER, MD, PhD | Diagnosis and Therapeutic Center, Hôtel-Dieu Hospital, Assistance Publique-Hôpitaux de Paris | Principal Investigator |
| Juliette VAY-DEMOUY, MSc, PhD | Diagnosis and Therapeutic Center, Hôtel-Dieu Hospital, Assistance Publique-Hôpitaux de Paris |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Diagnosis and Therapeutic Center, Hôtel-Dieu Hospital | Paris | IDF | 75004 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| D000074822 | Treatment Adherence and Compliance |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D015438 | Health Behavior |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Ability of HBPM Quality of the HBPM : Number of measurements carried out over 3 days (18 measurements over 3 days according to protocol) then divided into 4 categories: performance (18 measurements), average performance (17 to 15 measurements), average performance (14 to 12 measurements or less), poor performance (11 measures or less). |
| Medical consultation, from 2 months to 12 months after inclusion |
| Rate of Blood pressure control | Difference between inclusion and the Medical consultation, from 2 months to 12 months after inclusion | Medical consultation, from 2 months to 12 months after inclusion |
| Rate of therapeutic adjustments | Rate of therapeutic adjustments due to side effects | Medical consultation, from 2 months to 12 months after inclusion |
| Rate of therapeutic adjustments | Rate of therapeutic adjustments due to uncontrolled hypertension | Medical consultation, from 2 months to 12 months after inclusion |
| Rate of therapeutic adjustments | Rate of therapeutic adjustments : other reason | Medical consultation, from 2 months to 12 months after inclusion |
| Study Director |